NORTHWEST BIOTHERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
NWBO$0.19-0.6%Stored close · as of Jun 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| 21.1 | | Subsidiaries of the Registrant |
| | | |
| 21.2 | | Certificate of Incorporation on Change of Name |
| | | |
| 31.1 | Certification of President (Principal Executive Officer and Principal Financial and Accounting Officer), Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| | | |
| 32.1 | | Certification of President, Chief Executive Officer and Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| | | |
| 101.INS | | Inline XBRL Instance Document. |
| | ||
| 101.SCH | | Inline XBRL Schema Document. |
| | ||
| 101.CAL | | Inline XBRL Calculation Linkbase Document. |
| | ||
| 101.DEF | | Inline XBRL Definition Linkbase Document. |
| | ||
| 101.LAB | | Inline XBRL Label Linkbase Document. |
| | ||
| 101.PRE | | Inline XBRL Presentation Linkbase Document. |
| | | |
| 104 | | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL (included as Exhibit 101). |
- Filed herewith
** Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.